Recent data from Hong Kong's stock exchange reveals that on July 16th, J.P. Morgan increased its stake in Asymchem Laboratories (Tianjin) Co., Ltd. (SEHK: 06821). The transaction involved the purchase of 185,950 shares at a price of HK$130.859 per share, amounting to a total investment of approximately HK$24.33 million.

Following this acquisition, J.P. Morgan's total shareholding in the company has risen to about 2.3471 million shares. This new position represents approximately 8.43% of the company's issued shares.